Status:
COMPLETED
Theta Phase-specific TMS to Modulate Prefrontal Activity
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Approach/Avoidance Behavior
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the causal link between the phase of ongoing theta oscillations in the prefrontal cortex and approach/avoidance (Ap/Av) behavior in adults using theta phase-sp...
Detailed Description
Approach/avoidance (Ap/Av) behavior is a reliable marker of the emotional processes in the human brain and a robust predictor of mood disorders. Although existing scientific studies found a correlatio...
Eligibility Criteria
Inclusion
- Age between 18 and 65 years old.
- Confident level of English language.
Exclusion
- Chronic condition that requires pharmacological treatment over the course of study participation.
- Metallic or electric implant in the head, neck, or chest area or otherwise MRI-noncompatible implants.
- History or evidence of seizures, head injuries with loss of consciousness, chronic neurological or mental disorder.
- Pregnancy or breast-feeding.
- History or evidence of alcohol or drug addiction.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT05416138
Start Date
November 1 2022
End Date
August 31 2024
Last Update
December 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455